89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,774,793 | -9.2% | 827,383 | +11.4% | 0.01% | -14.3% |
| Q2 2023 | $14,069,086 | +30.0% | 742,432 | +4.4% | 0.01% | +40.0% |
| Q1 2023 | $10,825,971 | +584.3% | 710,832 | +69.4% | 0.01% | +400.0% |
| Q1 2022 | $1,582,000 | -85.0% | 419,560 | -47.8% | 0.00% | -75.0% |
| Q4 2021 | $10,514,000 | -33.4% | 804,420 | -0.2% | 0.00% | -33.3% |
| Q3 2021 | $15,791,000 | +10.9% | 806,039 | +5.8% | 0.01% | +20.0% |
| Q2 2021 | $14,244,000 | -12.3% | 761,739 | +11.0% | 0.01% | -28.6% |
| Q1 2021 | $16,245,000 | -2.8% | 686,039 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $16,718,000 | -4.8% | 686,039 | +0.2% | 0.01% | -22.2% |
| Q3 2020 | $17,562,000 | +136.8% | 684,400 | +205.8% | 0.01% | +125.0% |
| Q2 2020 | $7,417,000 | +31.3% | 223,800 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,651,000 | -14.0% | 223,800 | -10.5% | 0.00% | +33.3% |
| Q4 2019 | $6,573,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |